IRIDEX (NASDAQ:IRIX) Coverage Initiated by Analysts at StockNews.com

StockNews.com assumed coverage on shares of IRIDEX (NASDAQ:IRIX) in a research note issued on Tuesday. The firm set a “hold” rating on the medical equipment provider’s stock.

IRIDEX Price Performance

IRIX stock opened at $0.95 on Tuesday. IRIDEX has a one year low of $0.78 and a one year high of $3.65. The firm has a 50-day moving average of $1.42 and a two-hundred day moving average of $1.61. The firm has a market capitalization of $15.80 million, a PE ratio of -1.42 and a beta of 0.94. The company has a current ratio of 1.54, a quick ratio of 0.85 and a debt-to-equity ratio of 0.55.

IRIDEX Company Profile

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments.